LPR/PRD_000560
Lisinopril
Created: | 2002-11-25 |
Last modified: | 2020-06-05 |
LPR/PRD_000560 is described in the Biologically Interesting Molecule Reference Dictionary (BIRD).
The representative PDB ID is 1J36.
Find related ligands: |
---|
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 60 |
Chiral Atom Count | 3 |
Bond Count | 61 |
Aromatic Bond Count | 6 |
Chemical Component Summary | |
---|---|
Name | Lisinopril |
Synonyms | LISINOPRIL |
Systematic Name (OpenEye OEToolkits) | (2S)-1-[(2S)-6-amino-2-[[(2S)-1-hydroxy-1-oxo-4-phenyl-butan-2-yl]amino]hexanoyl]pyrrolidine-2-carboxylic acid |
Formula | C21 H31 N3 O5 |
Molecular Weight | 405.488 |
Type | NON-POLYMER |
Chemical Descriptors | |||
---|---|---|---|
Type | Program | Version | Descriptor |
SMILES | ACDLabs | 10.04 | O=C(O)C2N(C(=O)C(NC(C(=O)O)CCc1ccccc1)CCCCN)CCC2 |
SMILES | CACTVS | 3.341 | NCCCC[CH](N[CH](CCc1ccccc1)C(O)=O)C(=O)N2CCC[CH]2C(O)=O |
SMILES | OpenEye OEToolkits | 1.5.0 | c1ccc(cc1)CCC(C(=O)O)NC(CCCCN)C(=O)N2CCCC2C(=O)O |
Canonical SMILES | CACTVS | 3.341 | NCCCC[C@H](N[C@@H](CCc1ccccc1)C(O)=O)C(=O)N2CCC[C@H]2C(O)=O |
Canonical SMILES | OpenEye OEToolkits | 1.5.0 | c1ccc(cc1)CC[C@@H](C(=O)O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)O |
InChI | InChI | 1.03 | InChI=1S/C21H31N3O5/c22-13-5-4-9-16(19(25)24-14-6-10-18(24)21(28)29)23-17(20(26)27)12-11-15-7-2-1-3-8-15/h1-3,7-8,16-18,23H,4-6,9-14,22H2,(H,26,27)(H,28,29)/t16-,17-,18-/m0/s1 |
InChIKey | InChI | 1.03 | RLAWWYSOJDYHDC-BZSNNMDCSA-N |
Drug Info: DrugBank
DrugBank ID | DB00722 |
---|---|
Name | Lisinopril |
Groups |
|
Description | Lisinopril is an angiotensin converting enzyme inhibitor (ACEI) used to treat hypertension, heart failure, and myocardial infarction.[L8384,L8387,L8390] Lisinopril and [captopril] are the only ACEIs that are not prodrugs.[A184853] It functions by inhibition of angiotensin converting enzyme as well as the renin angiotensin aldosterone system.[A184781,A184808,A184817] ACEIs are commonly used as a first line therapy in the treatment of hypertension, along with thiazide diuretics or beta blockers.[A184844] Lisinopril was granted FDA approval on 29 December 1987.[L8384] |
Synonyms |
|
Brand Names |
|
Indication | Lisinopril is indicated for the treatment of acute myocardial infarction, hypertension in patients ≥6 years, and as an adjunct therapy for heart failure.[L8384,L8387] A combination product with hydrochlorothiazide is indicated for the treatment of hypertension.[L8390] |
Categories |
|
ATC-Code |
|
CAS number | 76547-98-3 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Angiotensin-converting enzyme | MGAASGRRGPGLLLPLPLLLLLPPQPALALDPGLQPGNFSADEAGAQLFA... | unknown | inhibitor |
Renin | MDGWRRMPRWGLLLLLWGSCTFGLPTDTTTFKRIFLKRMPSIRESLKERG... | unknown | inhibitor |
Solute carrier family 15 member 1 | MGMSKSHSFFGYPLSIFFIVVNEFCERFSYYGMRAILILYFTNFISWDDN... | unknown | substrate,inhibitor |
Solute carrier family 15 member 2 | MNPFQKNESKETLFSPVSIEEVPPRPPSPPKKPSPTICGSNYPLSIAFIV... | unknown | substrate |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL1237 |
PubChem | 11865407, 5362119, 139146300 |
ChEMBL | CHEMBL1237 |
ChEBI | CHEBI:43755 |